Fábián Emília, Varga Albert, Picano Eugenio, Vajo Zoltan, Rónaszéki Aladár, Csanády Miklós
Department of Cardiology, Elizabeth Hospital, Budapest, Hungary.
Am J Cardiol. 2004 Sep 1;94(5):652-5. doi: 10.1016/j.amjcard.2004.05.035.
Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p < 0.0001) decrease in total cholesterol, a 38% (p < 0.0001) decrease in low-density lipoprotein cholesterol levels, and 7% a (p < 0.0001) increase in high-density lipoprotein cholesterol levels, without significant changes in triglyceride levels. Brachial artery flow-mediated dilation increased significantly (52% relative increase, p < 0.0001), and the time to > 1-mm ST-segment depression during stress testing was longer by the end of the study (p < 0.0001).
患有轻度高胆固醇血症的心脏X综合征患者被随机分为安慰剂组(n = 20)或辛伐他汀20毫克/天组(n = 20)。在辛伐他汀组中,总胆固醇显著降低(26%;p < 0.0001),低密度脂蛋白胆固醇水平降低38%(p < 0.0001),高密度脂蛋白胆固醇水平升高7%(p < 0.0001),甘油三酯水平无显著变化。肱动脉血流介导的舒张显著增加(相对增加52%,p < 0.0001),并且在应激测试期间ST段压低> 1毫米的时间在研究结束时延长(p < 0.0001)。